June 8, 2016 / 12:22 PM / a year ago

BRIEF-Aptose Biosciences, CrystalGenomics sign cancer drug deal

1 Min Read

June 8 (Reuters) - Aptose Biosciences Inc

* Co and crystalgenomics says exclusive global option and license agreement focused on development of cg026806 (cg'806) Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below